The Impact of Renal Tissue Procurement at Bedside on Specimen Adequacy and Best Practices

Jacob T. Wooldridge, Amy Davis, Wayne G. Fischer, Mohamed F. Khalil, Min Zhang, Marjan Afrouzian

Research output: Contribution to journalArticle

Abstract

Objectives: Renal biopsy is the gold standard for the diagnosis of both native and allograft renal diseases. We studied the impact of tissue procurement at bedside (TPB) omission on the adequacy of renal biopsies. Methods: We compared 120 renal biopsies collected during 2015 using TPB with 111 renal biopsies collected during 2016 when TPB was discontinued. Adequacy criteria were applied as follows: by light microscopy, 10 glomeruli and two arteries for allograft biopsies and seven glomeruli for native biopsies. At least one glomerulus was considered adequate for immunofluorescence and electron microscopy in both groups. Results: The rate of inadequacies in allograft biopsies increased significantly, from 12.50% to 21.61% (P < .05), when TPB was discontinued. Conclusions: Elimination of TPB service had a negative impact on allograft specimen adequacy. Repeat biopsies add cost and delay patient care. Institutions should take this into consideration when considering omission of TPB.

Original languageEnglish (US)
Pages (from-to)205-208
Number of pages4
JournalAmerican Journal of Clinical Pathology
Volume151
Issue number2
DOIs
StatePublished - Jan 7 2019

Fingerprint

Tissue and Organ Procurement
Practice Guidelines
Kidney
Biopsy
Allografts
Fluorescence Microscopy
Microscopy
Electron Microscopy
Patient Care
Arteries
Light
Costs and Cost Analysis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

The Impact of Renal Tissue Procurement at Bedside on Specimen Adequacy and Best Practices. / Wooldridge, Jacob T.; Davis, Amy; Fischer, Wayne G.; Khalil, Mohamed F.; Zhang, Min; Afrouzian, Marjan.

In: American Journal of Clinical Pathology, Vol. 151, No. 2, 07.01.2019, p. 205-208.

Research output: Contribution to journalArticle

Wooldridge, Jacob T. ; Davis, Amy ; Fischer, Wayne G. ; Khalil, Mohamed F. ; Zhang, Min ; Afrouzian, Marjan. / The Impact of Renal Tissue Procurement at Bedside on Specimen Adequacy and Best Practices. In: American Journal of Clinical Pathology. 2019 ; Vol. 151, No. 2. pp. 205-208.
@article{043e86bab4fe47c8874f79a6d03aeffc,
title = "The Impact of Renal Tissue Procurement at Bedside on Specimen Adequacy and Best Practices",
abstract = "Objectives: Renal biopsy is the gold standard for the diagnosis of both native and allograft renal diseases. We studied the impact of tissue procurement at bedside (TPB) omission on the adequacy of renal biopsies. Methods: We compared 120 renal biopsies collected during 2015 using TPB with 111 renal biopsies collected during 2016 when TPB was discontinued. Adequacy criteria were applied as follows: by light microscopy, 10 glomeruli and two arteries for allograft biopsies and seven glomeruli for native biopsies. At least one glomerulus was considered adequate for immunofluorescence and electron microscopy in both groups. Results: The rate of inadequacies in allograft biopsies increased significantly, from 12.50{\%} to 21.61{\%} (P < .05), when TPB was discontinued. Conclusions: Elimination of TPB service had a negative impact on allograft specimen adequacy. Repeat biopsies add cost and delay patient care. Institutions should take this into consideration when considering omission of TPB.",
author = "Wooldridge, {Jacob T.} and Amy Davis and Fischer, {Wayne G.} and Khalil, {Mohamed F.} and Min Zhang and Marjan Afrouzian",
year = "2019",
month = "1",
day = "7",
doi = "10.1093/ajcp/aqy120",
language = "English (US)",
volume = "151",
pages = "205--208",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "2",

}

TY - JOUR

T1 - The Impact of Renal Tissue Procurement at Bedside on Specimen Adequacy and Best Practices

AU - Wooldridge, Jacob T.

AU - Davis, Amy

AU - Fischer, Wayne G.

AU - Khalil, Mohamed F.

AU - Zhang, Min

AU - Afrouzian, Marjan

PY - 2019/1/7

Y1 - 2019/1/7

N2 - Objectives: Renal biopsy is the gold standard for the diagnosis of both native and allograft renal diseases. We studied the impact of tissue procurement at bedside (TPB) omission on the adequacy of renal biopsies. Methods: We compared 120 renal biopsies collected during 2015 using TPB with 111 renal biopsies collected during 2016 when TPB was discontinued. Adequacy criteria were applied as follows: by light microscopy, 10 glomeruli and two arteries for allograft biopsies and seven glomeruli for native biopsies. At least one glomerulus was considered adequate for immunofluorescence and electron microscopy in both groups. Results: The rate of inadequacies in allograft biopsies increased significantly, from 12.50% to 21.61% (P < .05), when TPB was discontinued. Conclusions: Elimination of TPB service had a negative impact on allograft specimen adequacy. Repeat biopsies add cost and delay patient care. Institutions should take this into consideration when considering omission of TPB.

AB - Objectives: Renal biopsy is the gold standard for the diagnosis of both native and allograft renal diseases. We studied the impact of tissue procurement at bedside (TPB) omission on the adequacy of renal biopsies. Methods: We compared 120 renal biopsies collected during 2015 using TPB with 111 renal biopsies collected during 2016 when TPB was discontinued. Adequacy criteria were applied as follows: by light microscopy, 10 glomeruli and two arteries for allograft biopsies and seven glomeruli for native biopsies. At least one glomerulus was considered adequate for immunofluorescence and electron microscopy in both groups. Results: The rate of inadequacies in allograft biopsies increased significantly, from 12.50% to 21.61% (P < .05), when TPB was discontinued. Conclusions: Elimination of TPB service had a negative impact on allograft specimen adequacy. Repeat biopsies add cost and delay patient care. Institutions should take this into consideration when considering omission of TPB.

UR - http://www.scopus.com/inward/record.url?scp=85059235642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059235642&partnerID=8YFLogxK

U2 - 10.1093/ajcp/aqy120

DO - 10.1093/ajcp/aqy120

M3 - Article

VL - 151

SP - 205

EP - 208

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 2

ER -